We are delighted to announce a new collaboration with one of Australia’s leading research organisations; the Commonwealth Scientific and Industrial Research Organisation (CSIRO), to apply their expertise in our product development pipeline.
We will be working together with CSIRO’s Biomedical Imaging Group to enhance our MR image analysis software for the measurement of liver fibrosis. The liver fibrosis project will utilise a number of software components and algorithms, packaged within an image processing and viewing platform. The group’s wide ranging expertise has the potential to complement our development pipeline.
Dr Salvado, head of the CSIRO’s Biomedical Imaging Group said:
“Working with Resonance Health is a perfect partnership to translate our world-class research to the clinic, ultimately benefiting doctors and patients, while supporting successful Australian company leverage its research and development pipeline internationally.”
This work has been partially funded by the Research Connections stream from the Department of Industry and Science Entrepreneurs’ Infrastructure Programme. For more information on the programme please click here.
We expect the outcomes of this research to become available toward the end of 2015.
To read the full ASX announcement please click here.